HIGHLIGHTS
- who: Ting-Yi Lin et al. from the Department of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan have published the research: The Latest Evidence of Erythropoietin in the Treatment of Glaucoma, in the Journal: (JOURNAL)
- what: In the review of animal studies concerning the local or systemic administration of EPO in glaucoma, no significant adverse events were reported .
- how: Terminal 11 of 17 deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) was used in the study as an indicator for neuronal cell apoptosis. The authors conducted another study investigating . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.